Sugi Predict

Sugi Predict / Targets / TRA2B

TRA2B

Transformer-2 protein homolog beta · P62995 · TRA2B on Sugi Atlas →

0 patent compounds predicted against TRA2B, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TRA2B by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS PHASE2COMPLETED
Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer PHASE1/PHASE2RECRUITING
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients PHASE2COMPLETED
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) PHASE1COMPLETED
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia PHASE1RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma PHASE1COMPLETED
Understanding, Diagnosis and Monitoring of Thyroid Hormone Action Defects nanRECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies nanRECRUITING
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism nanUNKNOWN
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA nanRECRUITING
Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models nanCOMPLETED
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
The Etiology and Progression of Brain Tumors nanCOMPLETED
Genetic Factors Affecting the Severity of Beta Thalassemia nanCOMPLETED
Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast Cancer nanUNKNOWN
Telomere Repair Gene Mutation in Inflammatory Bowel Disease nanCOMPLETED
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development nanCOMPLETED
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Study of Genotype and Phenotype Characterization in Duchenne Muscular Dystrophy With Small Mutations nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Investigation of Tumor Microenvironment After CRPC Along With Before and After Neoadjuvant Therapy for Prostate Cancer nanUNKNOWN
Novel Biomarkers in Inflammatory Bowel Disease nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TRA2B binder may also engage these)

ProteinNameSimilarity
P62996 — 1.000 P62996 →
Q3ZBT6 — 1.000 Q3ZBT6 →
P62997 — 1.000 P62997 →
Q6PFR5 — 1.000 Q6PFR5 →
Q13595 — 0.999 Q13595 →
Q62093 — 0.990 Q62093 →
Q5R1W5 — 0.989 Q5R1W5 →
SRSF2 Serine/arginine-rich splicing factor 2 0.989 landscape →
Q6PDU1 — 0.988 Q6PDU1 →
Q06A98 — 0.988 Q06A98 →
Q9LHP2 — 0.987 Q9LHP2 →
Q3MHR5 — 0.987 Q3MHR5 →
P30352 — 0.986 P30352 →
Q9V3V0 — 0.985 Q9V3V0 →
Q8L3X8 — 0.985 Q8L3X8 →
Q9SEU4 — 0.984 Q9SEU4 →
Q09511 — 0.984 Q09511 →
Q1PDV2 — 0.984 Q1PDV2 →
P19018 — 0.984 P19018 →
Q84TH4 — 0.984 Q84TH4 →
Q9R0U0 — 0.983 Q9R0U0 →
O75494 — 0.983 O75494 →
Q9FYB7 — 0.982 Q9FYB7 →
O22315 — 0.981 O22315 →
SRSF7 Serine/arginine-rich splicing factor 7 0.981 landscape →
Q9BRL6 — 0.981 Q9BRL6 →
A2RVS6 — 0.981 A2RVS6 →
O02008 — 0.981 O02008 →
Q28E41 — 0.981 Q28E41 →
Q69KL9 — 0.980 Q69KL9 →